PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. (CADTH Optimal Use Report, No. 1.2A.)

REFERENCES

1.
Menke J, Luthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010 Feb 15;105(4):502–510. [PubMed: 20152245]
2.
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010 Jul;123(7):638–645. [PubMed: 20609686]
3.
Marinigh R, Lip GYH, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827–837. [PubMed: 20813280]
4.
Savelieva I, Bajpai A, Camm AJ. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med. 2007;39(5):371–391. [PubMed: 17701479]
5.
Hankey GJ. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs? Curr Opin Neurol. 2010 Feb;23(1):65–72. [PubMed: 19949330]
6.
du Breuil AL, Umland EM. Outpatient management of anticoagulation therapy. Am Fam Physician. 2007 Apr 1;75(7):1031–1042. [PubMed: 17427618]
7.
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest. 2008 Jun;133(6 Suppl):160S–198S. [PubMed: 18574265]
8.
Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M.CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol [Internet] Jan, 2011. [cited 2011 May 18]. pp. 74–90. Available from: http://www​.onlinecjc​.ca/article/S0828-282X(10)00008-5​/fulltext. [PubMed: 21329865]
9.
Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost [Internet] Mar 1, 1993. [cited 2011 May 12]. pp. 236–239. Available from: https://openaccess​.leidenuniv​.nl/bitstream​/1887/1793/1/303_324.pdf. [PubMed: 8470047]
10.
Tsuyuki RT, Bungard T, Grant CM, Ackman ML. Anticoagulation clinics in North America: operational insights. Can J Hosp Pharm. 2008 Jul;61(4):245–246.
11.
Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007 Feb;32(1):21–29. [PubMed: 17286786]
12.
Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM) J Thromb Thrombolysis. 2007 Apr;23(2):83–91. [PubMed: 17221328]
13.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol [Internet] 2007. [cited 2011 Jul 14]. p. 10. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC1810543. [PMC free article: PMC1810543] [PubMed: 17302989]
14.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health [Internet] Jun, 1998. [cited 2011 Jul 14]. pp. 377–384. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC1756728/pdf/v052p00377.pdf. [PMC free article: PMC1756728] [PubMed: 9764259]
15.
Aziz F, Corder M, Wolffe J, Comerota AJ. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care. J Vasc Surg. 2011 Jul 7 Epub ahead of print. [PubMed: 21741791]
16.
Garton L, Crosby JF. A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability. J Thromb Thrombolysis. 2011 Nov;32(4):426–430. [PubMed: 21710189]
17.
Hall D, Buchanan J, Helms B, Eberts M, Mark S, Manolis C, et al. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy. 2011 Jul;31(7):686–694. [PubMed: 21923456]
18.
Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010 Apr;30(4):330–338. [PubMed: 20334453]
19.
Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy. 2008 Jan;28(1):20–26. [PubMed: 18154470]
20.
Fitzmaurice DA. Oral anticoagulation control: The European perspective. J Thromb Thrombolysis. 2006 Feb;21(1):95–100. [PubMed: 16475050]
21.
Edgeworth A, Coles EC. An evaluation of near-patient testing of anticoagulant control in general practice. Int J Health Care Qual Assur. 2010;23(4):410–421. [PubMed: 20535909]
22.
Christensen H, Lauterlein JJ, Sorensen PD, Petersen ER, Madsen JS, Brandslund I. Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemed J E Health. 2011 Apr;17(3):169–176. [PMC free article: PMC3079164] [PubMed: 21254841]
23.
McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA. Does self-management of oral anticoagulation therapy improve quality of life and anxiety? Fam Pract. 2011 Apr;28(2):134–140. [PubMed: 21068191]
24.
Gardiner C, Longair I, Pescott MA, Erwin H, Hills J, Machin SJ, et al. Self-monitoring of oral anticoagulation: does it work outside trial conditions? J Clin Pathol [Internet] Feb, 2009. [cited 2011 Jun 3]. pp. 168–171. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2629005. [PMC free article: PMC2629005] [PubMed: 19181634]
25.
O'Shea SI, Arcasoy MO, Samsa G, Cummings SE, Thames EH, Surwit RS, et al. Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation. J Thromb Thrombolysis. 2008 Aug;26(1):14–21. [PubMed: 17616845]
26.
McCahon D, Murray ET, Jowett S, Sandhar HS, Holder RL, Hussain S, et al. Patient self management of oral anticoagulation in routine care in the UK. J Clin Pathol [Internet] Nov, 2007. [cited 2011 Jun 13]. pp. 1263–1267. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2095473. [PMC free article: PMC2095473] [PubMed: 17259295]
27.
Harper P, Pollock D. Improved anticoagulant control in patients using home international normalized ratio testing and decision support provided through the internet. Intern Med J. 2011 Apr;41(4):332–337. [PubMed: 20546057]
28.
Salvador CH, Ruiz-Sanchez A, Gonzalez de Mingo MA, Carmona RM, Carrasco MP, Sagredo PG, et al. Evaluation of a telemedicine-based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy. IEEE Trans Inf Technol Biomed. 2008 Nov;12(6):696–706. [PubMed: 19000948]
29.
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost. 2009 Mar;101(3):487–494. [PubMed: 19277410]
30.
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. Br J Haematol [Internet] Oct, 2008. [cited 2011 Jun 13]. pp. 274–283. Available from: http:​//onlinelibrary​.wiley.com/doi/10.1111/j​.1365-2141.2008.07337.x/pdf. [PubMed: 18759767]
31.
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost. 2008 Jun;6(6):935–943. [PubMed: 18489430]
32.
Onundarson PT, Einarsdottir KA, Gudmundsdottir BR. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice. Int J Lab Hematol. 2008 Oct;30(5):382–389. [PubMed: 19046313]
33.
Bloomfield HE, Taylor BC, Krause A, Reddy P, Greer N, MacDonald R, et al. Safe and effective anticoagulation in the outpatient setting: a systematic review of the evidence [Internet] Washington (DC): Department of Veterans Affairs (US); Feb, 2011. [cited 2011 May 31]. (VA-ESP Project #09-009). Available from: http://www​.ncbi.nlm.nih​.gov/books/NBK54599/ [PubMed: 21595123]
34.
Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Thrombolysis. 2010 Nov;8(11):2418–2427. [PubMed: 20831620]
35.
Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI. Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm. 2009 May 15;66(10):916–925. [PubMed: 19420310]
36.
Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm [Internet] Apr, 2009. [cited 2011 May 12]. pp. 244–252. Available from: http://www​.amcp.org/data/jmcp/244-252​.pdf. [PubMed: 19326955]
37.
Dolan G, Smith LA, Collins S, Plumb JM. Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature. Curr Med Res Opin. 2008 May;24(5):1459–1472. [PubMed: 18402715]
38.
van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest [Internet] May, 2006. [cited 2011 May 12]. pp. 1155–1166. Available from: http://chestjournal​.chestpubs​.org/content/129/5/1155​.full.pdf+html. [PubMed: 16685005]
39.
Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2010;(4):CD003839. [PubMed: 20393937]
40.
Wells PS, Brown A, Jaffey J, McGahan L, Poon MC, Cimon K. Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis. Open Med [Internet] 2007. [cited 2011 Jun 20]. pp. e131–e146. Available from: http://www​.openmedicine​.ca/article/view/77/75. [PMC free article: PMC3113217] [PubMed: 21673942]
41.
Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess [Internet] Oct, 2007. [cited 2011 May 12]. pp. iii–66. Available from: http://www​.hta.ac.uk/1495. [PubMed: 17903392]
42.
Bloomfield HE, Krause A, Greer N, Taylor BC, MacDonald R, Rutks I, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med. 2011 Apr 5;154(7):472–482. [PubMed: 21464349]
Copyright © 2011 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Cover of Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence
Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence [Internet].
CADTH Optimal Use Report, No. 1.2A.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...